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Highlights 
 74,864 people who use drugs participated in the online Global Drug Survey 2014 
 Energy drink, caffeine tablet and spray use was reported by 69.2%, 24.5% and 4.9% 
 Greater energy drink use frequency was associated with  drug use 
 Greater use frequency was associated with hazardous drinking and poorer wellbeing 
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Abstract 
Objective: The study aims were to identify: i.) energy drink (ED), caffeine tablet, and 
caffeine intranasal spray use amongst a sample who report drug use, and ii.) the association 
between ED use frequency and demographic profile, drug use, hazardous drinking, and 
wellbeing. 
Method: Participants (n=74,864) who reported drug use completed the online 2014 Global 
Drug Survey. They provided data on demographics, ED use, and alcohol and drug use, 
completed the Alcohol Use Disorders Identification Test (AUDIT) and Personal Wellbeing 
Index (PWI), and reported whether they wished to reduce alcohol use. 
Results: Lifetime ED, caffeine tablet and intranasal caffeine spray use was reported by 
69.2%, 24.5% and 4.9%. Median age of ED initiation was 16 years. For those aged 16 to 37, 
median years using EDs increased from 4 to 17 years of consumption, where it declined 
thereafter. Greater ED use frequency was associated with: being male; under 21 years of age; 
studying; and past year caffeine tablet/intranasal spray, tobacco, cannabis, amphetamine, 
MDMA, and cocaine use. Past year, infrequent (1-4 days) and frequent (≥5 days) past month 
ED consumers reported higher AUDIT scores and lower PWI scores than lifetime abstainers; 
past month consumers were less likely to report a desire to reduce alcohol use. 
Conclusions: ED use is part of a complex interplay of drug use, alcohol problems, and 
poorer personal wellbeing, and ED use frequency may be a flag for current/future problems. 
Prospective research is required exploring where ED use fits within the trajectory of other 
alcohol and drug use. 
 
Keywords: energy drink; caffeine; alcohol; ecstasy, stimulant 
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1. Introduction 
 Caffeinated energy drinks (EDs) are stimulant beverages marketed to facilitate 
performance by reversing fatigue effects and increasing alertness (Heckman et al., 2010). 
EDs attained popularity following the formation of the Red Bull® brand in Austria in 1987, 
and the release of their product in the United States in 1997 (Reissig et al., 2009). Estimates 
of use are generally based on convenience samples within specific regions in the United 
States, Canada, Australia and Europe, with indications that consumption is normative 
amongst adolescents (Arria et al., 2014; Azagba et al., 2014; Gallimberti et al., 2013) and 
young adults (Arria et al., 2010; Berger et al., 2011; Lubman et al., 2013; Rudolph et al., 
2014). However, increasing adverse exposure presentations to emergency departments and 
poison information call centres (Gunja and Brown, 2012; Substance Abuse and Mental 
Health Service Administration, 2011, 2013), coupled with associations between consumption 
and risky behaviour (Arria et al., 2014), have generated public debate regarding whether 
regulation of these beverages would be appropriate. 
 In regards to risky behaviour, research has indicated that ED consumption is 
associated with increased alcohol consumption (e.g., Arria et al., 2010; Arria et al., 2011), 
tobacco consumption (e.g., Friis et al., 2014; Trapp et al., 2014b), nonmedical use of 
prescription drugs (e.g., Arria et al., 2010; Miller and Quigley, 2011), and illicit drug use 
(e.g., Terry-McElrath et al., 2014; Trapp et al., 2014b). Based on the pharmacological effects 
of ED and of alcohol, it has been hypothesised that simultaneous use of EDs with alcohol 
may promote increased alcohol intake by: i.) delaying onset of fatigue/off-setting the sedating 
effects of alcohol, ii.) reducing perception of intoxication, iii.) exacerbating disinhibiting 
effects of alcohol, and iv.) masking the taste of alcohol making consumption more 
pleasurable. Recent reviews provide mixed support for these assumptions, with consistent 
evidence of enhanced stimulation and priming effects (i.e., increased desire for more 
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alcohol), but conflicting findings regarding decreased perception of intoxication (McKetin et 
al., 2015; Peacock et al., 2014). However, not all consumers of EDs co-ingest, or even use, 
alcohol (Lubman et al., 2013), meaning that we need to look more broadly for explanations of 
the association between ED and alcohol and other drug use. Alternative explanations include: 
i.) common genetic, psychosocial and cultural risk factors which predispose caffeinated ED, 
alcohol and drug use (Arria et al., 2011; Kendler et al., 2006), ii.) ED marketing promoting 
the psychoactive effects of the beverage (Reissig et al., 2009), and iii.) caffeinated ED 
consumption resulting in ‘cross-sensitisation’ whereby the dopamine system is primed to 
respond in a rewarding and reinforcing manner to alcohol and other stimulant drugs (Arria et 
al., 2014; Ferré, 2013; Temple, 2009).  
 Several of these potential explanations are based on the premise of a dose-response 
relationship, whereby increased frequency of ED intake inflates risk of reporting hazardous 
alcohol use and using other drugs. However, few of the aforementioned studies have studied 
the link between the frequency of ED use and degree of alcohol and drug-related problems. 
Arria et al. (Arria et al., 2011) found that high frequency ED consumers (≥52 days of use in 
the past year) were more likely to meet alcohol dependence criteria than low-frequency ED 
consumers (≤51 days) and Velazquez and colleagues (Velazquez et al., 2012) showed that a 
one day increase in past month ED use was associated with an increased risk of heavier 
drinking by 80%. Whilst providing a strong basis to suggest that higher frequency ED use 
may be associated with greater problems, these analyses did not take into account the 
potential continuum in ED consumption frequency from lifetime abstinence to daily use.  
 The majority of our knowledge regarding ED consumption patterns and associated 
behaviours stems from research with secondary school and university student samples in the 
US, Australia and Europe (Arria et al., 2014; Velazquez et al., 2012). Given that market-
leading ED brands are reportedly available in over 75% of countries worldwide (Red Bull, 
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2015), it is critical to explore this relationship on a global level. It is also important to place 
these products in the context of other non-traditional caffeine products marketed as enhancing 
energy, such as caffeine tablets and more recently caffeine intranasal sprays and sublingual 
strips. The latter two forms only available since 2013 offer the possibility of a more rapid 
onset of action and potentially of more intense effects and more unwanted effects related to 
peak plasma levels (such as headache and heart palpitations). In this study, we draw on a very 
large global non-probability sample of people who use drugs, including alcohol. The specific 
objectives were to: 
1. Describe ED, caffeine tablet, and intranasal spray consumption patterns amongst a 
large international sample who report drug use; 
2. Identify the demographic and alcohol and drug use correlates of ED use frequency 
(from lifetime abstinence to regular use); and 
3. Assess whether or not frequency of ED consumption is associated with severity of 
alcohol problems, desire to reduce alcohol use, and subjective wellbeing.  
 As aforementioned, previous studies have established the link between frequency of 
ED consumption and hazardous alcohol use. However, there has been no research exploring 
whether ED consumers are more or less motivated to change their alcohol use (motivation for 
change being a predictor of reductions in alcohol use; Adamson et al., 2009). As ED 
consumers are typically more risky, and experience greater negative consequences (Arria et 
al., 2010; Arria et al., 2011; Malinauskas et al., 2007), we anticipated findings indicating that 
heavier ED consumers would be less likely to report motivation to change alcohol use. In line 
with this, we also extended existing research showing a positive association between ED use 
and depression and anxiety (Richards and Smith, 2016), anticipating greater frequency of use 
would be associated with poorer overall wellbeing. By studying hazardous alcohol use, desire 
to reduce alcohol use, and overall wellbeing, we hoped to determine whether greater 
6 
 
frequency of ED use could be a possible flag from a clinical perspective for intervention or 
treatment.  
 
2. Material and Method 
2.1 Design 
 The Global Drug Survey (GDS) runs the world’s biggest drug survey, open to all 
individuals aged 16 years of age or older. Using an anonymous on-line survey hosted on an 
encrypted server (https://www.globalrugsurvey.com) GDS uses an international network of 
media partners (such as Huffington Post, Ziet Online, Fairfax Media, The Guardian and 
Stuff.co.nz) to promote participation in the survey. The media partners act as hubs with 
onward promotion through social media (such as Twitter, Facebook and Reddit). This 
methodology (based on a decade of work by this research group; McCambridge et al., 2007; 
Winstock et al., 2001) allows for the rapid assessment and identification of alcohol, licit and 
illicit drugs based on monitoring of large sentinel sample of people who use drugs. 
Discussion of methods (utility, validity and limitations) has been published elsewhere (Bellis 
et al., 2015; McCambridge et al., 2007; Winstock et al., 2001; Winstock et al., 2011). Ethical 
approval was received from the Joint South London and Maudsley and Institute of Psychiatry 
NHS Research Ethics Committee. In this study, data from the GDS 2014 (open between 
November 11 and December 29, 2013) was examined. 
 
2.2 Measures 
 The survey offers a drugs screen that allows subsequent sections of the survey to be 
tailored based on the individual’s recent drug use experience. For all substances including 
EDs, participants reported lifetime, past year and past month use, days of use in the past 
month, and age of initiation. In addition to demographics (age, sex, current paid employment, 
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whether they were currently studying any qualification, and country of origin), participants 
were asked about their use of alcohol, tobacco, cannabis, 3,4-
methylenedioxymethamphetamine (MDMA), amphetamines (excluding MDMA), and 
cocaine, as well as over 140 other drugs. The 10-item Alcohol Use Disorders Identification 
Test (AUDIT; Babor et al., 2001) was administered as a measure of alcohol consumption; 
higher scores are indicative of more problematic use (cut-off score of 8 for harmful alcohol 
use; Babor et al., 2001). Past year alcohol consumers were also asked if they would like to 
drink less alcohol over the next 12 months (no/yes). The Personal Wellbeing Index (PWI; 
ranging from 0 to 80) was administered to assess subjective wellbeing; lower scores are 
indicative of poorer wellbeing (International Wellbeing Group, 2013).  
 
2.3 Data Analysis 
 Data were cleaned to remove cases who did not report any alcohol or licit/illicit drug 
use in their lifetime, cases which had missing data on key variables (e.g., age, sex, drug 
screen items), data capture glitches, duplicate entries and cases with positive reporting of 
using a fake drug (Xenorap). Given the number of respondents and the extensive number of 
questions, it is not surprising that non-core items included in the present analyses generated 
missing responses. Complete-case analyses were used given limited gain from undertaking 
complex missing-data imputation in such cases (Penny and Atkinson, 2012). Valid N is 
reported for each statistic.  
 Percentages are reported for categorical data and means and standard deviations are 
reported for continuous data; median and inter-quartile range (IQR) were reported where 
continuous data were count or deemed highly skewed. Non-parametric test of trends were 
performed for demographic and alcohol and drug use variables (i.e., male, <21 years, 
employed, studying, AUDIT score ≥8, past year caffeine tablet, caffeine intranasal spray, 
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tobacco, cannabis, MDMA, amphetamine, and cocaine use) across ordered ED consumer 
frequency groups (‘never’, ‘prior to last year’, ‘last year’, ‘last month’, ‘fortnightly-weekly’, 
‘regular 5-12 days past month’, ‘frequent 13-30 days past month’ consumer) using Stata 
Statistical Software version 14 (StataCorp, College Station, TX). Hierarchical linear and 
logistic regression models were performed to determine the unique contribution of ED 
drinking frequency (entered in Model 2) to AUDIT score and PWI score (linear) and desire to 
reduce alcohol use (logistic), over and above known demographic risk factors (i.e., age, sex, 
employment, studying) (Arria et al., 2011; Berger et al., 2011) for ED use (entered in Model 
1). Analyses with alcohol-related dependent outcomes (AUDIT and desire to reduce alcohol 
use) were restricted to those participants who reported past year alcohol use. The 
aforementioned linear and logistic analyses were adjusted for intra-group correlation by 
country of origin. Given anticipated divergence in findings across countries, as sensitivity 
analyses we also ran: i.) multi-level mixed linear and logistic models (Stata commands mixed 
and meqrlogit, respectively), including country as a random effect, and ii.) hierarchical linear 
and logistic regression models separately for the most heavily-represented countries in the 
sample (Germany, US, UK, and Australia) to demonstrate generalizability of findings (see 
Supplementary Materials).  
 
3. Results 
3.1 Sample Characteristics  
 The total number of participants was 78,819, of which 3,955 were excluded after the 
cleaning process (final sample: n=74,864). Over one-quarter of respondents were recruited 
from Germany (29.7%, n=22,232); other significant nation contributors included the UK 
(9.6%, n=7,174), US (8.6%, n=6,423), and Australia (7.7%, n=5,789). The majority of the 
sample was male (67.2%, n=49,293), with a median age of 26 years (IQR 22-35); nearly 
9 
 
three-quarters were employed (72.5%, n=52,184) and two-fifths (43.5%, n=31,700) were 
currently studying.  
 
3.2 ED and other Novel Caffeine Product Use  
3.2.1 Energy Drink Use 
 Two-thirds of the sample had ever consumed caffeinated EDs; median age of 
initiation was 16 years (Table 1). Past year use was reported by 47.5% of the total sample 
(two-thirds of those who had ever used EDs).  
 Figure 1 provides a breakdown of the percentage of participants within each age 
group who reported past year ED use, and median years of ED use amongst consumers within 
each age group. A declining percentage reported past year ED use with age; specifically, 
three-fifths of 16 year olds reported past ED year use compared to one-tenth or less of those 
aged 55 or older. From those aged 16 to 37, median years using EDs increased from 4 to 17 
years of consumption, where it declined thereafter. In regards to past year ED use by country, 
51.0% (n=11,344) of participants from Germany reported past year ED use, 44.9% (n=3,222) 
from the UK, 41.6% (n=2,670) from the US, and 33.8% (n=1,957) from Australia.  
 Past month ED use was reported by 32.3% of the total sample (nearly half of those 
who had ever used EDs) (Table 1). These consumers had ingested EDs on a near weekly 
basis in the past month. Figure 2 highlights the distribution of ED consumption within the 
past month. Of those who had consumed ED in the past month, 59.7% (n=14,435) had 
consumed EDs more than fortnightly (i.e., more than once every two weeks), and 4.1% 
(n=995) reported daily use.  
3.2.2 Caffeine Tablets and Intranasal Caffeine Spray Use 
 Caffeine tablets and intranasal caffeine spray were less popular than ED: one-quarter 
and one-twentieth of the total sample reported lifetime caffeine tablet and caffeine intranasal 
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spray use (2.2% and 1.5% of the total sample reported past year use) (Table 1). Past year use 
of caffeine tablet and intranasal caffeine spray use was typically reported by adolescent and 
young adult participants (Figure 1), although it is important to note that caffeine spray was 
only released onto the market in approximately 2013. Whilst participants reported an older 
age of initiation for tablets and intranasal spray compared to ED (Table 1), frequency of use 
amongst past month consumers was similar for tablets and ED, but higher in the case of 
intranasal spray (equivalent to 2-3 times per week). Of those who reported past year use of 
caffeine tablets and spray, 78.1% (n=3,779) and 68.3% (n=1,119) had also used EDs in the 
past year, respectively. 
 
3.3 Demographic and Alcohol and Drug Use Correlates of ED Use Frequency 
 Participants were grouped into seven categories on the basis of ED use:  
 ‘Non-consumers’: never used ED in lifetime (30.8%; n=23,029) 
 ‘Prior consumers’: used ED in their lifetime but not in the last year (21.8%; n=16,287)  
 ‘Last year consumers’: used ED in the last year but not in the last month (15.2%; 
n=11,375) 
 ‘Last month consumers’: used ED one day in the past month (7.2%; n=5,422) 
 ‘Fortnightly-weekly consumers’: used ED 2-4 days in the past month (11.3%; n=8,497) 
 ‘Regular consumers’: used ED 5-12 days in the past month (8.5%; n=6,372) 
 ‘Frequent consumers’: used ED 13-30 days in the past month (5.2%; n=3,882) 
 Non-parametric test of trends revealed a significant trend for age (<21 years), sex, 
currently studying, AUDIT score (score ≥8), and past year caffeine tablet, caffeine intranasal 
spray, tobacco, cannabis, MDMA, amphetamine use according to ED use frequency 
(ps<.001); there was no significant trend for current paid employment (p=.225).  
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 Inspection of descriptive statistics showed ED consumers were predominantly male, 
however, the percentage of males was greater amongst those groups who reported past year 
ED use versus ‘prior consumers’ and ‘non-consumers’ (Figure 3). The percentage of 
adolescents within each group generally increased as a function of ED use frequency, with 
over one-quarter of ‘regular consumers’ aged 20 years old or younger. No clear pattern was 
evident in regards to likelihood of current paid employment on the basis of ED consumption 
frequency, with the highest percentage of employed persons amongst ‘prior consumers’ and 
‘frequent consumers’. However, those groups who reported any past year ED use were more 
likely to report currently studying as compared to ‘prior consumers’ and ‘non-consumers’.  
 In regards to other caffeine use, the percentage of people reporting caffeine tablet use 
increased as a function of ED use frequency, with 14.3% of ‘frequent consumers’ reporting 
past year caffeine tablet use versus 8.5% of ‘last year consumers’, and 2.2% of ‘non-
consumers’. Caffeine intranasal spray use followed a similar pattern.  
 The percentage of people out of the total sample exceeding the AUDIT cut-off 
indicative of hazardous alcohol use generally increased as a function of ED use frequency. 
The percentage of people exceeding the cut-off was relatively stable within past month 
consumer groups, with the exception of a decrease in persons exceeding the cut-off from the 
‘recent consumers’ group to the frequent consumers’ group. This was supported by the 
bivariate correlation between days of past month ED use and AUDIT score (restricted to past 
month ED consumers), which showed a significant weak negative relationship between the 
two (r=-.016, p=.014). 
 Past year tobacco, cannabis, MDMA, amphetamine, and cocaine use followed a 
similar pattern, with a substantial increase in the percentage reporting past year use from non-
past year consumers (‘non-consumers’ and ‘prior consumers’) to those past year consumer 
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groups, with a decrease in percentage of participants reporting use from the ‘frequent 
consumers’ group to the ‘regular consumers’ group.  
 
3.4 Frequency of ED Use as a Correlate of Hazardous Drinking  
 The results of hierarchical regression predicting AUDIT score, desire to cut back 
alcohol use, and PWI score accounting for age, sex, and education and working in step 1 and 
ED consumption in step 2 (with the reference category non-consumers) are presented in 
Table 2. For these analyses we combined the ‘non-consumer’ and ‘prior consumer’ groups 
(now labeled ‘non-consumers’) and the ‘last month consumers’ and ‘fortnightly-to-weekly 
consumers’ (now labeled ‘last month consumers’). As Figure 1 depicts, a curvilinear 
relationship between age and ED consumption was observed. As such the data were analyzed 
including a quadratic term for age. However, this quadratic term was not statistically 
significant and was therefore removed for parsimony.  
 Frequency of ED use was associated with AUDIT scores. Specifically, in the total 
sample there was a statistically-significant 1.07 unit increase (indicative of more hazardous 
drinking) in AUDIT score for the ‘last year consumers’ compared to ‘non-consumers; 1.61 
unit increase for ‘last month consumers’, and 1.89 unit increase for ‘frequent consumers’ 
relative to ‘non-consumers’. Subsequent contrast analyses revealed that AUDIT score 
increased with greater frequency of ED use. Specifically, the coefficients for ‘frequent 
consumers’ and ‘last month consumers’ were significantly greater than for ‘last year 
consumers’ (ps<.001), with a larger coefficient for ‘frequent consumers’ relative to ‘last 
month consumers’(p=.048). These findings were also evident in the multi-level mixed linear 
regression sensitivity analyses (see Supplementary Materials1).  
3.5 Frequency of ED Use as a Correlate of Desire to Reduce Alcohol Use  
                                                             
1 Supplementary material can be found by accessing the online version of this paper at 
http://dx.doi.org and by entering doi:... 
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 Frequency of ED use was also significantly associated with desire to reduce alcohol 
use in the next 12 months amongst alcohol consumers after controlling for demographics. 
Specifically, the ‘last year consumers’ and ‘last month consumers’ had a significantly greater 
odds ratio of reporting desire to reduce alcohol use compared to ‘non-consumers’. A 
statistically significant association was not observed for ‘frequent consumers’. Contrasts 
revealed no significant difference in the odds of reporting desire to reduce alcohol use for 
‘last year consumers’ and ‘last month consumers’ (p=.878), although both had greater odds 
than ‘frequent consumers’ (p=.006 and p=.005, respectively).  
 AUDIT score was added as a third step in this model to determine whether ED use 
frequency was associated with desire to reduce alcohol use over and above hazardous alcohol 
use. In contrast to the previous step, the odds of reporting desire to reduce alcohol use were 
statistically lower for ‘last month consumers’ (OR=0.90, 95%CI 0.86-0.95) and ‘frequent 
consumers’ (OR=0.72, 95%CI 0.64-0.82), compared to ‘non-consumers’, with no statistically 
significant association for ‘last month consumers’ (OR=1.00, 95%CI 0.94-1.06). Contrasts 
revealed lower odds for ‘frequent consumers’ relative to ‘last month consumers’ (p<.001), 
who in turn had lower odds than ‘last year consumers’ (p<.001). These findings were evident 
in the multi-level mixed linear regression sensitivity analyses (see Supplementary 
Materials2).  
3.6 Frequency of ED Use as a Correlate of Personal Wellbeing 
 Frequency of ED use was also associated with higher PWI scores in the total sample 
(i.e., those who had and had not consumed alcohol) after controlling for demographics. 
Specifically, there was a statistically significant 0.77 unit decrease (indicative of poorer 
wellbeing) in PWI score for the ‘last year consumers’ compared to ‘non-consumers; 0.66 unit 
decrease for ‘last month consumers’, and 2.18 unit decrease for ‘frequent consumers’. 
                                                             
2 Supplementary material can be found by accessing the online version of this paper at 
http://dx.doi.org and by entering doi:... 
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Contrast analyses revealed no statistically significant difference in coefficients for ‘last year 
consumers’ and ‘last month consumers’ (p=4.19), although the coefficient for ‘frequent 
consumers’ was significantly greater than that for both these groups (ps<.001). These 
findings were evident in the multi-level mixed linear regression sensitivity analyses (see 
Supplementary Materials2). 
 
4. Discussion 
4.1 ED and other Novel Caffeine Product Use 
 This research suggests widespread exposure to EDs amongst those who have ever 
used drugs: over two-thirds of this international sample had tried EDs at some point in their 
lifetime, and almost half reported past year use. This is consistent with recent research 
showing that the majority of other high-risk groups for ED use (e.g., adolescents and 
university students) have consumed these beverages within their lifetime (Arria et al., 2011; 
Gallimberti et al., 2013; Lubman et al., 2013; Trapp et al., 2014b), with monthly or more 
frequent use common amongst these populations.  
 Median age of ED initiation for the total sample was 16 years. However, examination 
of duration of ED use for past year consumers currently aged 16 showed they had been 
consuming EDs for a median of four years, suggesting initiation of use around 12 years of 
age. Qualitative research indicates increasing familiarity with, popularity of, and access to, 
ED amongst children and adolescents (Costa et al., 2014). However, to the authors’ 
knowledge, this is one of the first studies published to quantitatively assess the age at of ED 
initiation. While the European Food Safety Authority (2015) were unable to determine a safe 
level of caffeine intake for children due to insufficient evidence, recent systematic reviews 
have highlighted that children and adolescents are particularly vulnerable to negative acute 
physiological side-effects, as well as dependence and withdrawal (Seifert, 2011; Temple, 
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2009). Relevant to this sample of people who use drugs, children and adolescents may be 
particularly vulnerable to caffeine’s reinforcing effects. Caffeine use may result in cross-
sensitisation to alcohol and other drugs, whereby rewarding responses to other psychoactive 
drugs is enhanced following habitual use of caffeine (Temple, 2009). This growing body of 
evidence, plus a lack of data regarding long-term outcomes of ED use during childhood and 
adolescence, reinforces arguments for a precautionary approach to ED use in this period, and 
discussion of age restrictions on sales, better labelling, and targeted education. We should 
note that EDs were first introduced in the US in 1997, and the number of countries in which 
EDs are available has increased considerably in the last decade. Thus, the period of possible 
exposure may vary by country, and we may see further shifts in patterns of initiation and 
duration of use with further market expansion.  
 Normalisation of ED use stands in contrast to use of other ‘non-traditional’ caffeine 
products. These non-traditional products, compared to EDs, were generally first used at an 
older age, and, in the case of intranasal spray, used more frequently. While caffeine tablets 
have been available for longer than EDs, intranasal caffeine spray is a relatively new product, 
potentially explaining: i) lower rates of use amongst the total sample, and ii) high rates of 
past year use amongst lifetime consumers. Large overlap between those reporting ED use and 
use of these products suggests that use of other non-traditional caffeine products may be 
strongly related to ED use. 
 
4.2 Demographic and Alcohol and Drug Use Correlates of ED Use Frequency 
 Over half of past month consumers reported using EDs on a more than fortnightly 
basis, however less than 5% used EDs every day. These findings suggest that ED use is 
frequent but not typically part of daily routine, for this sample. The norm of using binary 
comparisons in this field, often between ‘ED consumers’ versus ‘non-ED consumers’ 
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(Marczinski et al., 2015), may disguise important findings based on a continuum of use from 
lifetime abstinence to daily use. This is best illustrated when considering past year 
amphetamine use reported by ED consumption frequency: 4.5% of lifetime ED abstainers, 
7.8% of those who had consumed EDs in their lifetime (but not in the past year), 15.5% of 
those who had consumed EDs in the past year (but not in the past month), and 20.4% of those 
who had consumed ED on a weekly basis, reported ever using amphetamine. Greater 
frequency of ED use was also associated with greater likelihood of: being male; being under 
21 years of age; currently studying; and past year caffeine tablet, caffeine intranasal spray, 
tobacco, cannabis, MDMA, and cocaine use.  
 These findings highlight the importance of conducting analyses that account for 
heterogeneity in frequency of use. It reinforces calls for prospective research exploring where 
ED use is positioned within the trajectory of substance use: as a marker of general propensity 
to engage in potentially hazardous behaviours or a behaviour which directly elevates risk of 
alcohol and other drug use (Arria et al., 2014). Further, these findings also suggest that 
greater frequency of ED use could be considered as a marker of current use of alcohol and 
other drugs, or of individuals at risk of engaging in use of other licit and illicit drugs use in 
the future. 
 
4.3 Frequency of ED Use as a Correlate of Hazardous Drinking and Subjective 
Wellbeing  
 Building on this notion of ED use as an indicator of risk of alcohol and other drug use, 
previous research with a purposive sample of university students has shown increased 
likelihood of meeting criteria for DSM-IV alcohol dependence disorder for high frequency 
ED consumers (≥52 days in past year) versus low frequency (1-51 days) and non-consumers 
(0 days) (Arria et al., 2011). In contrast, the current study with a purpose sample of people 
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who use drugs showed that those who had used ED in the last year had a higher AUDIT score 
indicative of hazardous alcohol use relative to ED lifetime abstainers, with higher scores with 
increased frequency of use. These findings suggest that knowing the individual’s full history 
of ED use can be important as a potential indicator of problematic alcohol use. 
 Those who reported both ED use in the past month were less likely to report a desire 
to cut back on alcohol use relative to ED lifetime abstainers (after controlling for 
demographics and AUDIT score). It may be that individuals who consume ED have less 
insight into their drinking behaviours; findings that higher frequency ED use often co-occurs 
amongst an array of high risk behaviours supports this notion, and previous research has 
shown higher risk of alcohol dependence amongst higher-frequency ED consumers (≥52 days 
in the past year) relative to lower-frequency and non-consumers (Arria et al., 2011). It may 
also be that co-consumption of alcohol with EDs reduce hangover effects, making alcohol use 
less subjectively problematic. Use to reduce hangover symptoms is flagged by a significant 
minority of consumers (O'Brien et al., 2008), although these studies have typically focused 
on university students, with few experimental studies exploring this possible phenomenon 
(Rohsenow et al., 2014). Regardless, frequency of ED use could serve as flag in clinical 
settings for potential hazardous alcohol use, important given possible stigma associated with 
reporting problematic alcohol use (Fortney et al., 2004). Continuing with this premise, 
evidence from the current and previous studies (Trapp et al., 2014a) showing poorer 
wellbeing amongst ED consumers suggests that assessing history of use might flag those at 
greater risk of mental health problems, and in need of help from a mental health professional.  
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4.4 Strengths and Limitations 
 This sample for this study is unique compared to existing studies, comprising 
participants at high risk of ED use recruited from across the globe rather than from 
homogenous groups such as university students (Arria et al., 2014) or emergency department 
attendees (Cotter et al., 2013). However, findings should not be seen as representative of all 
ED consumers more generally or all ED consumers who use drugs as sampling was 
purposive. Data were self-reported, although evidence points to sufficient validity and 
reliability of self-report in studies of alcohol and illicit drug use (Darke, 1998; Del Boca, 
2003). We were unable to exclude differences in trait impulsivity between consumers as an 
explanation for greater risk of hazardous drinking (and other outcomes) with increased 
frequency of ED use, as no such measure was included (Arria et al., 2014). We should also 
note that, whilst we collected data only on caffeinated EDs, we did not obtain information 
regarding ingredient profile of products, the typical volume ingested, and whether they were 
consumed simultaneously with other substances, thus restricting inferences regarding the 
pharmacological effects of consumption.  
 
4.5 Conclusion 
 Lifetime exposure to EDs was common amongst the sample, with indications of 
initiation of use around 12 years of age for young participants. The current results suggest 
that greater frequency of ED use might form part of an array of complex problems given the 
interplay between ED use, drug use, alcohol problems, and poorer personal wellbeing. A lack 
of prospective research exploring where ED use fits within the trajectory of other alcohol and 
drug use means that we cannot determine whether ED use is causative in elevating likelihood 
of high risk behaviours, or symptomatic; future research addressing this is critical given the 
early age of initiation reported here, and concerns that habitual caffeine use in adolescent 
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may result in cross-sensitisation to other psychoactive substances. Regardless, the current 
findings indicate that knowledge of history of ED use is important: from a research 
perspective for understanding and taking into account heterogeneity in frequency of use, and 
from a clinical perspective for acting as a possible flag of current and/or future hazardous 
drinking, drug use, and wellbeing. 
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Figure Legends 
Figure 1. The figure depicts: i) percentage of each age group who report past year ED, caffeine tablet, 
and caffeine intranasal spray use and ii) median years of ED use (current age minus age of initiation) 
amongst past year consumers within each age group. In regards to the latter outcome, of past year ED 
consumers (n=35,548), 34,130 reported both current age and age of ED initiation. Three-hundred and 
sixty-four past year consumers were excluded from analyses of median years of ED use as their 
duration of use was outside the possible range (<0 or >28 years). The maximum period of 27 years for 
duration of use was selected as the first ED was launched onto the market in 1987 (2014-1987=27 
years). 
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Figure 2. Percentage of past month ED consumers reporting days of ED use in the past month 
(n=24,173). 
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Figure 3. Percentage of participants who are male (A: n=73,393), younger than 21 years (B: 
n=73,533), currently employed (C: n=72,020) and currently studying (D: n=72,810) according to ED 
consumer group. ED: energy drink. 
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Figure 4. Percentage of participants (n=74,864) who reported past year caffeine tablet use (A); 
intranasal spray use (B); AUDIT cut-off score indicative of hazardous use (C), tobacco use (D); 
cannabis (E); MDMA (F); amphetamine (G); and cocaine (H) according to ED consumer group. The 
total sample was used for all analyses. ED: energy drink.  
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Table 1 
Lifetime and Recent Use of Caffeinated Products (n=74,864) 
 Energy Drinks Caffeine Tablets Intranasal Caffeine 
Spray 
Ever used % (n) 69.2 (51,835) 24.5 (18,326) 4.9 (3,698) 
Of lifetime consumers: 
Median age of first use (IQR) 
16 (14-19) 18 (16-20) 17 (15-20) 
Used last 12 months % (n) 
68.6 (35,548) 26.4 (4,837) 44.3 (1,639) 
Used last month % (n) 46.6 (24,173) 12.4 (2,280) 30.0 (1,110) 
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Table 2 
ED Consumption as a Predictor of Alcohol Consumers’ AUDIT Score, Desire to Reduce 
Alcohol Use, and Personal Wellbeing Index Score 
 AUDIT Score1 
(n=66,590) 
Desire to Reduce Alcohol 
Use2 
(n=66,237) 
Personal Wellbeing Index Score3 
(n=70,361) 
Model 
b (SE) p 
OR (95% 
CI) 
p b (SE) p 
Step 1       
Age (in 5-year 
groups) 
-0.34 (0.03) <.001 
1.06 (1.03-
1.10) 
<.001 -0.01 (0.07) .867 
Male 1.73 (0.08) <.001 
1.24 (1.16-
1.32) 
<.001 -1.70 (0.24) <.001 
Studying 0.18 (0.16) .264 
0.97 (0.85-
1.11) 
.678 2.58 (0.29) <.001 
Employed 0.05 (0.14) .702 
1.14 (1.05-
1.25) 
.002 3.94 (0.51) <.001 
Step 2       
Age (in 5-year 
groups) 
-0.22 (0.03) <.001 
1.07 (1.04-
1.11) 
<.001 -0.08 (0.08) .263 
Male 1.54 (0.08) <.001 
1.22 (1.14-
1.31) 
<.001 -1.57 (0.24) <.001 
Studying 0.19 (0.17) .257 
0.97 (0.85-
1.11) 
.669 2.56 (0.30) <.001 
Employed -0.01 (0.14) .984 
1.14 (1.05-
1.25) 
<.001 4.00 (0.51) <.001 
ED Consumer       
Non-Consumer (ref) -  - - - - 
Last Year Consumer 1.07 (0.08) <.001 
1.18 (1.13-
1.24) 
<.001 -0.77 (0.14) <.001 
Last Month 
Consumer (1-4 days 
past month) 
1.61 (0.07) <.001 
1.19 (1.14-
1.24) 
<.001 -0.66 (0.11) <.001 
Frequent Consumer 
(5+ days past month) 
1.89 (0.17) <.001 
1.04 (0.93-
1.16) 
.496 -2.18 (0.27) <.001 
Step 3       
Age (in 5-year 
groups) 
- - 1.14 (1.10-
1.17) 
<.001 
- - 
Male 
- - 0.93 (0.87-
1.01) 
.087 
- - 
Studying 
- - 0.94 (0.84-
1.05) 
.278 
- - 
Employed 
- - 1.19 (1.11-
1.29) 
<.001 
- - 
ED Consumer - -   - - 
Non-Consumer (ref) - - - - - - 
Last Year Consumer 
- - 1.00 (0.94-
1.06) 
.934 
- - 
Last Month 
Consumer (1-4 days 
past month) 
- - 
0.90 (0.86-
0.95) 
<.001 
- - 
Frequent Consumer 
(5+ days past month) 
- - 0.72 (0.64-
0.82) 
<.001 
- - 
AUDIT score 
- - 1.20 (1.18-
1.21) 
<.001 
- - 
Note. All demographic variables were categorical with the exception of age, which was 
treated as a continuous variable. Variables are bolded where statistically significant (p<.050). 
1 Linear hierarchical regression analyses were restricted to those participants who had 
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consumed alcohol in the preceding 12 months. Higher AUDIT scores are indicative of more 
hazardous alcohol use. 2Logistic hierarchical regression analyses for desire to reduce alcohol 
use in the next 12 months were restricted to those participants who had consumed alcohol in 
the preceding 12 months; AUDIT score was added in Step 3 of this model to determine the 
association between ED use and desire to reduce alcohol use after controlling for hazardous 
alcohol use. 3 Linear hierarchical regression analyses were conducted using the total sample; 
lower scores are equivalent to poorer subjective wellbeing. 
 
